Quince Therapeutics, Inc. logo

Quince Therapeutics, Inc.

QNCX • NASDAQ • Stock Fundamentals

Quince Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dirk Thye, with a market cap of $21.5M.

Market Cap$21.5M
Employees32.0
CEODirk Thye
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View report
Next EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Income StatementBalance SheetCash FlowSegments

Financials

Based on Q1 2026 filing

View all metrics
Quince Therapeutics, Inc. logo

Quince Therapeutics, Inc. FAQ

Common questions about Quince Therapeutics, Inc.

Quince Therapeutics, Inc. (QNCX) has a market capitalization of $21.5M and trades on NASDAQ.

Quince Therapeutics, Inc. has approximately 32 employees.